Product description

Clavamox Chewable tablets are an orally administered formulation for cats and dogs.

Active ingredients

Each Clavamox tablet contains:

Indications for use

Clavamox Chewable tablets are indicated in the treatment of:

• Dogs:

  • Skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus, non-β-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., and E. coli.
  • Periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. Clavamox Chewable tablets has been shown to be clinically effective for treating cases of canine periodontal disease.

• Cats:

  • Skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus, non-β-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., E. coli, and Pasteurella spp.
  • Urinary tract infections (cystitis) due to susceptible strains of E. coli.

Administration and dosage

• The dose should be prescribed using a combination of whole tablet strengths (62.5 mg, 125 mg, 250 mg, 375 mg). Do not remove from foil strip until ready to use. Even if the tablet is broken, the entire tablet should be consumed.

• Dogs:

  • The recommended dosage of Clavamox Chewable tablets is 6.25 mg/lb of body weight twice a day.
  • Skin and soft tissue infections such as abscesses, cellulitis, wounds, superficial/juvenile pyoderma, and periodontal infections should be treated for 5-7 days or for 48 hours after all symptoms have subsided. If no response is seen after 5 days of treatment, therapy should be discontinued and the case reevaluated. Deep pyoderma may require treatment for 21 days; the maximum duration of treatment should not exceed 30 days.

• Cats:

  • The recommended dosage of Clavamox Chewable tablets is 62.5 mg twice a day.
  • Skin and soft tissue infections such as abscesses and cellulitis/dermatitis should be treated for 5-7 days or for 48 hours after all symptoms have subsided, not to exceed 30 days. If no response is seen after 3 days of treatment, therapy should be discontinued and the case reevaluated.
  • Urinary tract infections may require treatment for 10-14 days or longer. The maximum duration of treatment should not exceed 30 days.

Prescribing information